<ѻýҕl>New Data on CD40 Ligand Inhibitor for Relapsing MSѻýҕl> Novel agent led to sustained reduction of new lesions at 24 weeks Nov 14, 2023 video
<ѻýҕl>Should MS Patients Stop Treatment as They Age?ѻýҕl> Enrique Alvarez, MD, PhD discusses the challenges of deciding whether patients can safely quit Nov 13, 2023 video
<ѻýҕl>Targeting Chronic Inflammation in Progressive MSѻýҕl> Our panel of experts discuss emerging data in the chronic active inflammation space Nov 10, 2023 video
<ѻýҕl>Biological Age Predicts Dementia; APOE4 and Tau Patterns; AI and MS Brain Changesѻýҕl> News and commentary from the world of neurology and neuroscience Nov 07, 2023
<ѻýҕl>Blood Test Detects MS Disability Worsening a Year Before It Occursѻýҕl> Neurofilament light is elevated before worsening, both with and without relapses Nov 06, 2023
<ѻýҕl>Central Vein Sign as an Imaging Biomarker of Multiple Sclerosisѻýҕl> Our panel of experts discuss emerging data that is leading to new MS diagnostic criteria Nov 03, 2023 video
<ѻýҕl>Probe of Alzheimer's Researcher Halted; Dementia and Triglycerides; Migraine Genesѻýҕl> News and commentary from the world of neurology and neuroscience Oct 31, 2023
<ѻýҕl>Emerging Biomarkers of Multiple Sclerosis in Blood and CSFѻýҕl> While promising, how they apply to individual patients remains a question Oct 27, 2023 video
<ѻýҕl>S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MSѻýҕl> Ozanimod led to test score improvements in interim analysis Oct 19, 2023
<ѻýҕl>BTK Inhibitor Reduces Brain Lesions in Relapsing MSѻýҕl> Subgroup analysis shows brain penetration Oct 19, 2023
<ѻýҕl>Neurofilament Light Predicts MS Worsening in Silent Progressionѻýҕl> NfL changes occurred in advance of, not coincident with, clinical worsening Oct 17, 2023
<ѻýҕl>Path to Multiple Sclerosis Cure on the Horizonѻýҕl> MS field faces immense opportunity to move beyond disease suppression, keynote speaker says Oct 15, 2023
<ѻýҕl>Subcutaneous Ocrelizumab Not Inferior to IV Infusionѻýҕl> Both provided rapid B-cell depletion Oct 14, 2023
<ѻýҕl>Novel Drug Shows Promise in Multiple Sclerosisѻýҕl> CD40 ligand inhibitor leads to sustained reduction of MRI disease activity Oct 13, 2023
<ѻýҕl>Chronic Stress and Dementia; Hormones and Brain Health; Dementia Protection Neurons?ѻýҕl> News and commentary from the world of neurology and neuroscience Oct 03, 2023
<ѻýҕl>Stem Cell Transplants Effective in MSѻýҕl> AHSCT shows long-term benefit in Swedish cohort Sep 29, 2023
<ѻýҕl>Theory Slammed as Pseudoscience; TBI and Cardiovascular Risk; AAN Shares Its Visionѻýҕl> News and commentary from the world of neurology and neuroscience Sep 26, 2023
<ѻýҕl>The Quest to Solve MS: 'It's a Story That's Optimistic'ѻýҕl> Stephen Hauser, MD, talks about The Face Laughs While the Brain Cries Sep 08, 2023
<ѻýҕl>Vaccines Not Linked to MS Flare-Upsѻýҕl> Nationwide French study might clear up a decade of doubts Sep 05, 2023
<ѻýҕl>First Multiple Sclerosis Biosimilar Approvedѻýҕl> Natalizumab-sztn gets a nod from the FDA Aug 25, 2023
<ѻýҕl>Alzheimer's Protector Genes; West Nile and MS; What a 101-Year-Old Neurologist Eatsѻýҕl> News and commentary from the world of neurology and neuroscience Aug 15, 2023
<ѻýҕl>Hand Motions Predict Memory Impairment; APOE4 Smell Loss; Alzheimer's Drug Guidanceѻýҕl> News and commentary from the world of neurology and neuroscience Aug 01, 2023
<ѻýҕl>Stem Cell Medical Tourism Leads to Meningitis in MS Patientѻýҕl> Difficult infection took weeks to identify; doctors warn about unproven treatments Jul 12, 2023
<ѻýҕl>MS Disease Severity Tied to Genetic Variantѻýҕl> Findings mark a significant breakthrough in understanding how MS progresses Jun 28, 2023
<ѻýҕl>Speech Predicts Alzheimer's; Afib and Dementia in Women; Who Gets Lecanemab?ѻýҕl> News and commentary from the world of neurology and neuroscience Jun 27, 2023
<ѻýҕl>Treatment May Delay Earliest MS Eventsѻýҕl> TERIS is the second trial to investigate radiologically isolated syndrome Apr 26, 2023
<ѻýҕl>Novel MS Drug Good as Gold in Phase II Studyѻýҕl> Yes, we mean element no. 79 on the periodic table Apr 25, 2023
<ѻýҕl>Detecting Alzheimer's in Speech; Manipulating CSF in Humans; Gut Microbiome and MSѻýҕl> News and commentary from the world of neurology and neuroscience Apr 04, 2023
<ѻýҕl>Cognitive Impairment in Multiple Sclerosis Tied to Dietѻýҕl> Mediterranean diet was strongest predictor of better cognitive scores Mar 03, 2023
<ѻýҕl>Man Presents With Episodic, One-Sided Facial Paralysisѻýҕl> Uncommon presentation of MS detailed in case report Feb 21, 2023
<ѻýҕl>Epstein-Barr/MS Link; How CBD Curtails Seizures; NIH Finds Rare Neurologic Diseaseѻýҕl> News and commentary from the world of neurology and neuroscience Feb 14, 2023
<ѻýҕl>Viruses Tied to Subsequent Dementia, Other Neurodegenerative Diseasesѻýҕl> Viral encephalitis and Alzheimer's disease showed strongest links Jan 30, 2023
<ѻýҕl>Isolation and Dementia Risk; High-Intensity Exercise and the Brain; Migraine and MSѻýҕl> News and commentary from the world of neurology and neuroscience Jan 17, 2023
<ѻýҕl>Anti-CD20 Agent Gains Approval for Multiple Sclerosisѻýҕl> FDA greenlights ublituximab for relapsing MS Dec 29, 2022
<ѻýҕl>Pragmatic Trials May Help Increase Minority Participation in MS Researchѻýҕl> DELIVER-MS shows racial and ethnic diversity in clinical trials can be improved Nov 02, 2022
<ѻýҕl>Higher Relapse Rate With Rituximab vs Ocrelizumab in MS Registry Dataѻýҕl> Rituximab did not show non-inferiority in comparative effectiveness study Nov 01, 2022
<ѻýҕl>Can First MS Symptoms Be Delayed?ѻýҕl> ARISE trial investigates radiologically isolated syndrome Oct 31, 2022
<ѻýҕl>New Evidence Sheds Light on Stem Cell Transplantation for Progressive MSѻýҕl> Disability, relapses no better than disease-modifying drug Oct 30, 2022
<ѻýҕl>No Excess Pregnancy, Infant Risks With Ocrelizumab for MSѻýҕl> Major congenital anomalies, other adverse outcomes were rare Oct 28, 2022
<ѻýҕl>Off-Label Drug Lowers Relapses in Multiple Sclerosisѻýҕl> Study paves way for rituximab to be considered for MS in some countries Jul 21, 2022